NCT04005417View on ClinicalTrials.gov

Meta-analysis of Stannous Fluoride Dentifrice and the Effects on Dentine Hypersensitivity

CompletedOBSERVATIONAL
Enrollment

1,036

Participants

Timeline

Start Date

January 8, 2018

Primary Completion Date

November 30, 2018

Study Completion Date

November 30, 2018

Conditions
Dentine Hypersensitivity
Interventions
DRUG

Stannous fluoride dentifrice

Stannous fluoride (0.454%) dentifrice

DRUG

Positive control dentifrice

Positive control dentifrice containing potassium nitrate or arginine.

DRUG

Negative control dentifrice

Negative control dentifrice containing either sodium fluoride (0.243%) or sodium monofluorophosphate (0.76%)

Trial Locations (1)

45040

Multiple P&G Investigation Clinical Sites, Cincinnati

All Listed Sponsors
lead

Procter and Gamble

INDUSTRY

NCT04005417 - Meta-analysis of Stannous Fluoride Dentifrice and the Effects on Dentine Hypersensitivity | Biotech Hunter | Biotech Hunter